A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously
A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously Summary This research introduces a novel biohybrid nanoparticle that combats cancer by triggering ferroptosis and enhancing immunotherapy. The nanoparticles target ferritin, the body’s iron storage protein, simultaneously activating endogenous iron…













